Search

Author/Creator Yee, Andrew J.

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma. (8th May 2018)

Authors:
O'Donnell, Elizabeth K.; Laubach, Jacob P.; Yee, Andrew J.; Chen, Tianqi; Huff, Carol Ann; Basile, Frank G.; Wade, Philip M.; Paba‐Prada, Claudia E.; Ghobrial, Irene M.; Schlossman, Robert L.; Burke, Jill N.; Harrington, Cynthia C.; Lively, Kathleen J.; Lyons, Hannah F.; Munshi, Nikhil C.; Anders...
Journal:
British journal of haematology
Issue:
Volume 182:Number 2(2018)
Page Start:
222
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients. Issue 9 (1st September 2016)

Authors:
Jurczyszyn, Artur; Olszewska-Szopa, Magdalena; Hungria, Vania; Crusoe, Edvan; Pika, Tomas; Delforge, Michel; Leleu, Xavier; Rasche, Leo; Nooka, Ajay K.; Druzd-Sitek, Agnieszka; Walewski, Jan; Davila, Julio; Caers, Jo; Maisnar, Vladimir; Gertz, Morie; Gentile, Massimo; Fantl, Dorotea; Mele, Giusep...
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 9(2016:Sep.)
Page Start:
2071
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide. (25th April 2014)

Authors:
Yee, Andrew J.; Hari, Parameswaran; Marcheselli, Raffaella; Mahindra, Anuj K.; Cirstea, Diana D.; Scullen, Tyler A.; Burke, Jill N.; Rodig, Scott J.; Hideshima, Teru; Laubach, Jacob P.; Ghobrial, Irene M.; Schlossman, Robert L.; Munshi, Nikhil C.; Anderson, Kenneth C.; Weller, Edie A.; Richardson...
Journal:
British journal of haematology
Issue:
Volume 166:Number 3(2014:Aug.)
Page Start:
401
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma. Issue 5 (18th February 2022)

Authors:
O'Gorman, Peter; Laubach, Jacob P.; O'Dwyer, Michael E.; Krawczyk, Janusz; Yee, Andrew J.; Gilligan, Oonagh; Cahill, Mary R.; Rosenblatt, Jacalyn; Quinn, John; Murphy, Philip T.; DiPietro, Heidi; Perera, Meegahage Ratnakanthi; Crotty, Gerard M.; Cummings, Kristen; Hayden, Patrick J.; Browne, Paul...
Journal:
American journal of hematology
Issue:
Volume 97:Issue 5(2022)
Page Start:
562
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients. (7th January 2018)

Authors:
Jurczyszyn, Artur; Radocha, Jakub; Davila, Julio; Fiala, Mark A.; Gozzetti, Alessandro; Grząśko, Norbert; Robak, Paweł; Hus, Iwona; Waszczuk‐Gajda, Anna; Guzicka‐Kazimierczak, Renata; Atilla, Erden; Mele, Giuseppe; Sawicki, Waldemar; Jayabalan, David S.; Charliński, Grzegorz; Szabo, Agoston G.; H...
Journal:
British journal of haematology
Issue:
Volume 180:Number 6(2018)
Page Start:
831
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗